20101011
 Corporate News: Corporate Watch   By Anonymous, The Wall Street Journal,  Oct 12, 2010  The stem-cell testing, which the company called the world's first clinical trial of embryonic stem-cell therapy in humans, is to restore spinal-cord function by injecting cells directly into the injured portion of a patient's spinal cord.   
